• Japanese
  • Korean
  • Chinese
Cover Image

Ocular Hypertension Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Ocular Hypertension Global Clinical Trials Review, H1, 2015" provides an overview of Ocular Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Ocular Hypertension 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Unaccomplished Trials of Ocular Hypertension 25
  • Subjects Recruited Over a Period of Time 28
  • Clinical Trials by Sponsor Type 29
  • Prominent Sponsors 30
  • Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials 31
  • Prominent Drugs 32
  • Latest Clinical Trials News on Ocular Hypertension 33
  • May 11, 2015: Promising preclinical data on NCX 667 for glaucoma presented at ARVO by Nicox 33
  • May 11, 2015: Promising preclinical data on NCX 470 for glaucoma presented at ARVO by Nicox 33
  • Apr 23, 2015: Aerie Pharmaceuticals Reports Initial Rhopressa Phase 3 Efficacy Results 33
  • Mar 24, 2015: Aerie Pharmaceuticals Completes Enrollment in Second Phase 3 Registration Trial of Rhopressa, Novel Triple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma 34
  • Clinical Trial Profiles 36
  • Clinical Trial Overview of Top Companies 36
  • Novartis AG 36
  • Clinical Trial Overview of Novartis AG 36
  • Actavis plc 43
  • Clinical Trial Overview of Actavis plc 43
  • Pfizer Inc. 49
  • Clinical Trial Overview of Pfizer Inc. 49
  • Santen Pharmaceutical Co., Ltd. 52
  • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 52
  • Aerie Pharmaceuticals, Inc. 55
  • Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 55
  • Valeant Pharmaceuticals International, Inc. 57
  • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 57
  • Merck & Co., Inc. 59
  • Clinical Trial Overview of Merck & Co., Inc. 59
  • QLT Inc. 60
  • Clinical Trial Overview of QLT Inc. 60
  • Mati Therapeutics Inc. 61
  • Clinical Trial Overview of Mati Therapeutics Inc. 61
  • Kowa Company, Ltd. 62
  • Clinical Trial Overview of Kowa Company, Ltd. 62
  • Clinical Trial Overview of Top Institutes / Government 63
  • Medical University of Vienna 63
  • Clinical Trial Overview of Medical University of Vienna 63
  • Aristotle University Of Thessaloniki 64
  • Clinical Trial Overview of Aristotle University Of Thessaloniki 64
  • University of Colorado Denver 65
  • Clinical Trial Overview of University of Colorado Denver 65
  • University of Sao Paulo 66
  • Clinical Trial Overview of University of Sao Paulo 66
  • Association for Research in Supporting System of Chronic Diseases 67
  • Clinical Trial Overview of Association for Research in Supporting System of Chronic Diseases 67
  • Department of Health, South Africa 68
  • Clinical Trial Overview of Department of Health, South Africa 68
  • IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 69
  • Clinical Trial Overview of IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 69
  • University Health Network 70
  • Clinical Trial Overview of University Health Network 70
  • University of Nebraska 71
  • Clinical Trial Overview of University of Nebraska 71
  • University of Parma 72
  • Clinical Trial Overview of University of Parma 72
  • Five Key Clinical Profiles 73

Appendix 100

  • Abbreviations 100
  • Definitions 100
  • Research Methodology 101
  • Secondary Research 101
  • About GlobalData 102
  • Contact Us 102
  • Disclaimer 102
  • Source 102

List of Tables

List of Tables

  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Region, 2015* 7
  • Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
  • Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
  • Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
  • Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
  • Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase, 2015* 21
  • Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
  • Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
  • Ocular Hypertension Therapeutics, Global, Suspended Clinical Trials, 2015* 25
  • Ocular Hypertension Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
  • Ocular Hypertension Therapeutics, Global, Terminated Clinical Trials, 2015* 27
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 43
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 49
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 52
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015* 55
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 57
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 59
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015* 60
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015* 61
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 62
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 63
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015* 64
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015* 65
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2015* 66
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Association for Research in Supporting System of Chronic Diseases, 2015* 67
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 68
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS, 2015* 69
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 70
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2015* 71
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Parma, 2015* 72

List of Figures

List of Figures

  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
  • Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
  • Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
  • Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
  • Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
  • Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
  • Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
  • Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
  • GlobalData Methodology 101
Show More
Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top